Volume 128, Issue 14 pp. 4537-4542
Zuschrift

Use of Three-Dimensional Arterial Models To Predict the In Vivo Behavior of Nanoparticles for Drug Delivery

Paninee Chetprayoon

Paninee Chetprayoon

Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Yamadaoka, Suita, Osaka, 565–0871 Japan

Search for more papers by this author
Dr. Michiya Matsusaki

Dr. Michiya Matsusaki

Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Yamadaoka, Suita, Osaka, 565–0871 Japan

Search for more papers by this author
Prof. Utako Yokoyama

Prof. Utako Yokoyama

Cardiovascular Research Institute, Yokohama City University, Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004 Japan

Search for more papers by this author
Takanori Tejima

Takanori Tejima

Cardiovascular Research Institute, Yokohama City University, Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004 Japan

Search for more papers by this author
Prof. Yoshihiro Ishikawa

Corresponding Author

Prof. Yoshihiro Ishikawa

Cardiovascular Research Institute, Yokohama City University, Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004 Japan

Search for more papers by this author
Prof. Mitsuru Akashi

Corresponding Author

Prof. Mitsuru Akashi

Department of Applied Chemistry, Graduate School of Engineering, Osaka University, Yamadaoka, Suita, Osaka, 565–0871 Japan

Search for more papers by this author
First published: 01 March 2016

Abstract

Nanomaterials have been widely used for applications in biomedical fields and could become indispensable in the near future. However, since it is difficult to optimize in vivo biological behavior in a 3D environment by using a single cell in vitro, there have been many failures in animal models. In vitro prediction systems using 3D human-tissue models reflecting the 3D location of cell types may be useful to better understand the biological characteristics of nanomaterials for optimization of their function. Herein we demonstrate the potential ability of 3D engineered human-arterial models for in vitro prediction of the in vivo behavior of nanoparticles for drug delivery. These models enabled optimization of the composition and size of the nanoparticles for targeting and treatment efficacy for atherosclerosis. In vivo experiments with atherosclerotic mice suggested excellent biological characteristics and potential treatment effects of the nanoparticles optimized in vitro.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.